Antibodies to a Conserved Influenza Head Interface Epitope Protect by an IgG Subtype-Dependent Mechanism

Vaccines to generate durable humoral immunity against antigenically evolving pathogens such as the influenza virus must elicit antibodies that recognize conserved epitopes. Analysis of single memory B cells from immunized human donors has led us to characterize a previously unrecognized epitope of i...

Full description

Saved in:
Bibliographic Details
Published inCell Vol. 177; no. 5; pp. 1124 - 1135.e16
Main Authors Watanabe, Akiko, McCarthy, Kevin R., Kuraoka, Masayuki, Schmidt, Aaron G., Adachi, Yu, Onodera, Taishi, Tonouchi, Keisuke, Caradonna, Timothy M., Bajic, Goran, Song, Shengli, McGee, Charles E., Sempowski, Gregory D., Feng, Feng, Urick, Patricia, Kepler, Thomas B., Takahashi, Yoshimasa, Harrison, Stephen C., Kelsoe, Garnett
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 16.05.2019
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Vaccines to generate durable humoral immunity against antigenically evolving pathogens such as the influenza virus must elicit antibodies that recognize conserved epitopes. Analysis of single memory B cells from immunized human donors has led us to characterize a previously unrecognized epitope of influenza hemagglutinin (HA) that is immunogenic in humans and conserved among influenza subtypes. Structures show that an unrelated antibody from a participant in an experimental infection protocol recognized the epitope as well. IgGs specific for this antigenic determinant do not block viral infection in vitro, but passive administration to mice affords robust IgG subtype-dependent protection against influenza infection. The epitope, occluded in the pre-fusion form of HA, is at the contact surface between HA head domains; reversible molecular “breathing” of the HA trimer can expose the interface to antibody and B cells. Antigens that present this broadly immunogenic HA epitope may be good candidates for inclusion in “universal” flu vaccines. [Display omitted] •Human B cells specific for a novel epitope on influenza A groups 1 and 2•Crystallography locates the epitope at the interface of the hemagglutinin head domains•Robust protection by antibodies to this epitope, dependent on IgG subclass•Protective, cross-group antibodies are encoded by diverse sets of Ig gene segments Antibodies targeting a novel site at the interface of the head domains of hemagglutinin provide broad, IgG-subclass-dependent protection against influenza.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
National Institutes of Health (NIH). National Institute of General Medical Sciences (NIGMS)
USDOE Office of Science (SC)
AC02-06CH11357; P41 GM103403; JP18fk0108051; P01 AI089618; U19 AI117892; R01 AI128832
AUTHOR CONTRIBUTIONS: G.K., M.K., Y.T., and S.C.H. designed research; A.W., K.R.M., M.K., A.G.S. Y.A., T.O., K.T., and T.M.C. performed research; F.F., P.U., and T.B.K. recruited and managed human subject materials; S.S., G.B, C.E.M., and G.D.S. provided critical reagents and assays; A.W., K.R.M., M.K., A.G.S., T.B.K., T.M.C., Y.T, S.C.H., and G.K. analyzed data; A.W. K.R.M., M.K., Y.T., S.C.H., and G.K. wrote the paper. T.M.C., G.B., T.B.K., and C.E.M. edited and revised the paper.
ISSN:0092-8674
1097-4172
1097-4172
DOI:10.1016/j.cell.2019.03.048